C-reactive protein and procalcitonin profile in ventilator-associated lower respiratory infections
- 1 December 2018
- journal article
- research article
- Published by Elsevier in Journal of Critical Care
- Vol. 48, 385-389
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistanceClinical Microbiology and Infection, 2012
- Biomarker-guided antibiotic therapy in adult critically ill patients: a critical reviewAnnals of Intensive Care, 2012
- Attributable Mortality of Ventilator-Associated Pneumonia: A Reappraisal Using Causal AnalysisAmerican Journal of Respiratory and Critical Care Medicine, 2011
- C-reactive protein in critically ill cancer patients with sepsis: influence of neutropeniaCritical Care, 2011
- Systematic Review and Meta-Analysis of the Efficacy of Appropriate Empiric Antibiotic Therapy for SepsisAntimicrobial Agents and Chemotherapy, 2010
- Clinical review: The role of biomarkers in the diagnosis and management of community-acquired pneumoniaCritical Care, 2010
- Procalcitonin for reduced antibiotic exposure in ventilator-associated pneumonia: a randomised studyEuropean Respiratory Journal, 2009
- Antimicrobial treatment for ventilator-associated tracheobronchitis: a randomized, controlled, multicenter studyCritical Care, 2008
- Procalcitonin in patients with and without immunosuppression and sepsisInfection, 1996
- American College of Chest Physicians/Society of Critical Care Medicine Consensus ConferenceCritical Care Medicine, 1992